GREY:ALEAF - Post by User
Post by
Oceanison Apr 09, 2021 2:23pm
130 Views
Post# 32967874
Would LOVE an Update on this release
Would LOVE an Update on this release ALEAFIA HEALTH APPROVED BY JANSSEN PHARMACEUTICALS TO ADMINISTER ANTIDEPRESSANT SPRAVATO®
GlobeNewswire JUL 24, 2020 07:15 AM EDT
- SPRAVATO® (esketamine) nasal spray uses the first new mechanism of action in decades to treat treatment resistant depression disorder
- Aleafia Health medical clinics along with select physicians and nurses now approved to administer and prescribe, following completion of Janssen Journey certification
- Offering expands Aleafia's health and wellness solutions to existing and prospective patients across Canada
- SPRAVATO® approved by the U.S. Food and Drug Administration and Health Canada